Feb 04, 2021 / 01:00PM GMT
Presentation
Feb 04, 2021 / 01:00PM GMT
=====================
Corporate Participants
=====================
* Alan Hippe
Roche Holding AG - Chief Financial & Information Officer
* Karl Mahler
Roche Holding AG - Head of IR
* Severin Schwan
Roche Holding AG - CEO & Executive Director
* Thomas Schinecker
Roche Holding AG - CEO of Roche Diagnostics
* William N. Anderson
Roche Holding AG - CEO of Roche Pharmaceuticals
=====================
Conference Call Participants
=====================
* Emmanuel Douglas Papadakis
Deutsche Bank AG, Research Division - Research Analyst
* Luisa Caroline Hector
Joh. Berenberg, Gossler & Co. KG, Research Division - Co-Head of Global Pharmaceutical Team
* Mark Douglas Purcell
Morgan Stanley, Research Division - Equity Analyst
* Matthew Weston
Crédit Suisse AG, Research Division - MD and Co-Head of European Pharmaceutical Equity Research
* Peter James Welford
Jefferies LLC, Research
Roche Holding AG
(STU:RHO6)
€
35.413
0.243 (0.69%)
Market Cap: 225.73 Bil
Enterprise Value: 257.19 Bil
PE Ratio: 20.18
PB Ratio: 7.36
GF Score: 85/100 Full Year 2020 Roche Holding AG Earnings Presentation Transcript
Feb 04, 2021 / 01:00PM GMT
Release Date Price:
€36.38
(+2.02%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot